Eagle Pharmaceuticals, Inc. (NASDAQ:EGRX) Q1 2019 Earnings Conference Call May 7, 2019 8:30 AM ET Company Participants Lisa Wilson - IR Scott Tarriff - Founder and CEO David Pernock - President and Chief Commercial Officer Pete Meyers - CFO, Principal Financial Officer and Principal Accounting Officer Adrian Hepner - EVP and CMO Conference Call Participants Brandon Folkes - Cantor Fitzgerald Ashley Ryu - RBC Capital Markets Tim Lugo - William Blair Operator Good day and welcome to today's program. My name i ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2018 or o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission File Number 001-36306 Eagle Pharmaceuticals, Inc. (Exact Name of Registrant as Specified in its Charter) Delaware 2834 20-8179278 (State or Other J ...

Eagle Pharmaceuticals Inc. (NASDAQ:EGRX) Q4 2018 Earnings Conference Call February 28, 2019 8:30 AM ET Company Participants Lisa Wilson – Investor Relations Scott Tarriff – Founder, Chief Executive Officer and Director David Pernock – President, Chief Commercial Officer Pete Meyers – Chief Financial Officer, Principal Financial Officer and Principal Accounting Officer Conference Call Participants Dan Busby – Randall Brandon Folkes – Cantor Fitzgerald Operator Good day and welcome to today’s program. My name ...